Tijori
Bliss GVS Pharma Ltd.
Market Capital
₹ 1,818 Cr.
P/E
25.61
Share Price
₹ 176.85 0.60 (0.34%)
  • Bliss GVS Pharma Ltd.
  • Overview
  • Connections
  • Financials
  • Benchmarking
  • Shareholding
  • Knowledge Base
  • Pharma Sector
  • Revenue Mix
  • Operational Metrics
  • Competitors
  • Customers
  • Price
  • Benchmarking
  • Growth Table
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results
  • Overview
  • Trend
  • Detailed
  • Recent News
  • Annual Reports
Revenue Mix
Therapeutic Area Break-Up
Source
Location Wise Break-Up
Source
Operational Metrics for Bliss GVS Pharma
1.33% (as of Mar 19)
Change in PAT with 1% Appreciation in FX Basket
Source
0.36% (as of Mar 19)
Management Compensation as a % of Sales
Source
Pharmaceuticals
2.70% (as of Mar 20)
R&D as a % of Total Sales
Source
Compare with Competitors


Competitors
- Anti-Malarial
Peer Name Market Cap.
Bliss Gvs Pharma Limited 1,818
IPCA Laboratories Limited 23,696
- Anti-Fungal
Peer Name Market Cap.
Bliss Gvs Pharma Limited 1,818
Gufic Biosciences Limited 864
Aarti Drugs Limited 5,922
- Anti - Infectives
Peer Name Market Cap.
Bliss Gvs Pharma Limited 1,818
Neuland Laboratories Limited 2,642
Indoco Remedies Limited 2,716
Gufic Biosciences Limited 864
Lincoln Pharmaceuticals Limited 462
Ind-Swift Limited 21
FDC Limited 4,767
Aarti Drugs Limited 5,922
AstraZeneca Pharma India Limited 8,733
Sanofi India Limited 18,784
IPCA Laboratories Limited 23,696
GlaxoSmithKline Pharmaceuticals Limited 24,654
Abbott India Limited 30,987
Alkem Laboratories Limited 33,065
Torrent Pharmaceuticals Limited 41,902
Cadila Healthcare Limited 44,420
Lupin Limited 45,705
Cipla Limited 63,674
Dr. Reddy's Laboratories Limited 73,861
Sun Pharmaceuticals Industries Limited 144,572
Show More
- Anti-Biotic
Peer Name Market Cap.
Bliss Gvs Pharma Limited 1,818
Dishman Carbogen Amics Limited 1,881
Marksans Pharma Limited 2,221
Aarti Drugs Limited 5,922
Aurobindo Pharma Limited 50,517
Show More
Investors
33.4%
Narsimha Shibroor Kamath
Is a Director at Bliss GVS Pharma
0.48%
Gautam Rasiklal Ashra
Is a Director at Bliss GVS Pharma
#
Vibha Gagan Sharma
Is a Director at Bliss GVS Pharma
#
Shruti Vishal Rao
Is a Director at Bliss GVS Pharma
9.8%
Arian Investment
5.7%
Gulbarga Trading And Investment
4.9%
Polus Global Fund(7)
-
Also invests in Share %
Shirpur Gold Refinery Limited
6.6
Zee Learn Limited
6.4
Bliss Gvs Pharma Limited
4.9
Gokaldas Exports Limited
4.4
Ansal Properties & Infrastructure Limited
2.2
Siti Cable Network Limited
1.4
MEP Infrastructure Developers Ltd
1.1
Infibeam Avenues Limited
1.1
4.9%
Arjun Gautam Ashra
3.6%
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund(7)
Is a Director at Electrosteel Steel
-
Also invests in Share %
Gujarat State Fertilizers & Chemicals Limited
7.2
eClerx Services Limited
4.4
Bliss Gvs Pharma Limited
3.6
Redington (India) Limited
3.6
Gujarat Narmada Valley Fertilizers and Chemicals Limited
3.1
FDC Limited
1.7
Zensar Technologies Limited
1.6
Deepak Fertilizers and Petrochemicals Corporation Limited
1.3
3.1%
Aspire Emerging Fund(7)
-
Also invests in Share %
GSS Infotech Limited
7.4
Bliss Gvs Pharma Limited
3.1
Rushil Decor Limited
3.1
Karuturi Global Limited
2.7
A2Z Infra Engineering Limited
1.6
Electrotherm (India) Limited
1.4
Filatex India Limited
1.1
Genesys International Corporation Limited
1.1
2.9%
Gautam R Ashra
1.5%
Globe Capital Market(2)
-
Also invests in Share %
Bombay Dyeing & Mfg Company Limited
1.6
Bliss Gvs Pharma Limited
1.5
Ganesha Ecosphere Limited
1.4
0.08%
Mangesh Ghanashyam Wagle
0.01%
Mangesh Ghanashyam Wagle - Huf
#
Kanji Pitamber
#
Antara Gautam Ashra
#
Mamta Gautam Ashra
#
Vijayaben Kanji Ashra
#
Genteel Trading Co.
#
Kanji Forex
Show More
Customers
Intas Pharmaceuticals Limited
Mankind Pharma
Sun Pharmaceuticals Industries Limited
Alkem Laboratories Limited
Sanofi India Limited

Source


Financial
833
Add/Edit Companies
Business
Price
176.85 0.60 (0.34%)
Benchmarking
The Benchmarking section has been moved to the next tab. Please click
here


Growth Table
(in Rs. Cr.) 1yr 2yr 3yr 4yr 5yr 6yr 7yr 8yr 9yr 10yr
View more
View less
* Share price growth is updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020